Cargando…
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
Autores principales: | Villegas, Carolina, Poza, María, Talayero, Paloma, Teller, José Manuel Caro, Zafra, Denis, Garcia, Cristina, Vera, Elena, Hidalgo, Marta, Lopez, Nieves, Cuellar, Clara, Zamanillo, Irene, Íñiguez, Rodrigo, Paz-Artal, Estela, Aguado, José M., Martinez-Lopez, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314614/ https://www.ncbi.nlm.nih.gov/pubmed/32583087 http://dx.doi.org/10.1007/s00277-020-04160-w |
Ejemplares similares
-
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021) -
Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
por: Lasa-Lázaro, María, et al.
Publicado: (2023) -
IL-6–based mortality risk model for hospitalized patients with COVID-19
por: Laguna-Goya, Rocio, et al.
Publicado: (2020) -
Perforin gene variant A91V in young patients with severe COVID-19
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020) -
PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022)